|
May 22
|
Orion to host Capital Markets Day today, 22 May 2025, in Helsinki
|
|
May 21
|
Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers
|
|
Apr 25
|
Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease
|
|
Apr 25
|
European Dividend Stocks To Consider In April 2025
|
|
Apr 24
|
Composition of the Nomination Committee of Orion Corporation
|
|
Apr 23
|
Orion Group Interim Report January–March 2025
|
|
Apr 22
|
Invitation to Orion’s Capital Markets Day on 22 May 2025
|
|
Mar 11
|
Orion Group Financial Statement documents 2024 and Remuneration Report published
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Julia Macharey
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – René Lindell
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Olli Huotari
|
|
Mar 11
|
Orion Corporation: Managers’ transactions – Liisa Hurme
|
|
Mar 10
|
Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025
|
|
Mar 10
|
Orion to open new Biologics R&D Centre in Cambridge, UK in 2025 to support global growth strategy, considers reorganizing some work in Turku
|
|
Feb 28
|
Orion Corporation: Managers’ transactions – Outi Vaarala
|
|
Feb 28
|
Orion Corporation: Managers’ transactions – Niclas Lindstedt
|
|
Feb 27
|
Orion Corporation: Managers’ transactions – Satu Ahomäki
|
|
Feb 27
|
Orion Corporation: Managers’ transactions – Hao Pan
|
|
Feb 25
|
Orion Corporation: The Board of Directors of Orion Corporation decided on incentive programs for the company’s key persons
|